Health in Sur 315 indicators covering health for Sur. IndicatorLatest Year10-yr change Rank Neonatal tetanus - number of reported cases, gaps filled 0 2025 — 1st Pertussis - number of reported cases, gaps filled 8 2025 — 1st Total tetanus - number of reported cases, gaps filled 0 2025 down 100.0% 1st Diphtheria - number of reported cases, gaps filled 0 2025 — 1st Measles - number of reported cases, gaps filled 0 2025 — 1st Number of under-five deaths, annual growth rate -3.39 % change on previous year 2024 down 39.5% 2nd Number of infant deaths, annual growth rate -3.03 % change on previous year 2024 down 37.6% 2nd Number of neonatal deaths, annual growth rate -3.67 % change on previous year 2024 down 43.1% 2nd Measles - number of reported cases, annual growth rate -100 % change on previous year 1991 down 155.0% 1st Pertussis - number of reported cases, annual growth rate -100 % change on previous year 2023 down 150.0% 1st Total tetanus - number of reported cases, annual growth rate -100 % change on previous year 2021 — 1st Pertussis - number of reported cases 8 2025 — 1st Total tetanus - number of reported cases 0 2025 down 100.0% 1st Diphtheria - number of reported cases 0 2025 — 1st Measles - number of reported cases 0 2025 — 1st Neonatal tetanus - number of reported cases 0 2025 — 1st Number of neonatal deaths 105 2024 down 30.9% 2nd Number of under-five deaths 171 2024 down 29.0% 2nd Number of infant deaths 160 2024 down 27.9% 2nd Thinness among children and adolescents, BMI-for-age < -2 standard 4.3% 2024 up 6.9% 2nd Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) 6.6% 2024 down 3.4% 2nd Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) 30.8% 2024 up 27.1% 1st Overweight among children and adolescents, BMI-for-age > +1 standard 35.9% 2024 up 23.5% 1st Obesity among children and adolescents, BMI-for-age > +2 standard 20.4% 2024 up 28.3% 1st Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) 59.9% 2024 up 11.1% 1st Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 30.8% 2024 up 26.8% 1st Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 59.8% 2024 up 11.4% 1st Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) 6.6% 2024 down 4.2% 1st Neonatal mortality rate 9.67 2024 down 27.3% 1st Infant mortality rate (probability of dying between birth and age 1) 14.76 2024 down 24.1% 1st Under-five mortality rate 15.79 2024 down 25.2% 1st Number of maternal deaths 9.1 2023 down 34.4% 1st Maternal mortality ratio 83.64 2023 down 31.0% 1st Mortality rate among children ages 5 to 9 years 2 2024 up 33.2% 1st Number of deaths among adolescents 23 2024 up 27.8% 1st Adolescent mortality rate 2.08 2024 up 30.7% 1st Number of deaths among children 5 to 14 years of age 45 2024 up 32.4% 1st Mortality rate for 5-14 year-olds 4.08 2024 up 31.9% 1st Number of deaths among children ages 5 to 9 years 22 2024 up 37.5% 1st Diphtheria - number of reported cases, annual growth rate -100 % change on previous year 1984 down 50.0% 1st Population with primary reliance on polluting fuels and technologies 0.015 2023 down 58.4% 1st Population with primary reliance on clean fuels and technologies for 0.1962 2023 up 25.3% 2nd Proportion of population with primary reliance on polluting fuels and 7.1% 2023 down 62.0% 1st Neonatal tetanus - number of reported cases, annual growth rate -100 % change on previous year 2007 unchanged 1st Proportion of population with primary reliance on fuels and 5.6% 2023 down 68.0% 1st Population with primary reliance on fuels and technologies for 0.0118 2023 down 64.9% 1st Diabetes treatment coverage, crude 47.77 2022 up 1.3% 2nd Prevalence of diabetes, age-standardized 20.76 2022 up 18.9% 2nd Prevalence of diabetes, crude 20.64 2022 up 26.9% 2nd Diabetes treatment coverage, age-standardized 47.81 2022 down 0.9% 2nd Measles-containing-vaccine second-dose (MCV2) immunization coverage 52.0% 2025 up 147.6% 2nd Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) 80.0% 2025 up 9.6% 2nd Measles-containing-vaccine first-dose (MCV1) immunization coverage 67.0% 2025 down 11.8% 2nd Diphtheria tetanus toxoid and pertussis third-dose (DTP3) 80.0% 2025 up 9.6% 2nd Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 80.0% 2025 up 8.1% 2nd Hib (Hib3) immunization coverage among 1-year-olds (%) 80.0% 2025 up 9.6% 2nd New HIV infections 0.73 2025 up 5.8% 1st Mean HDL cholesterol, age-standardized 1.1 2018 down 8.3% 2nd Mean Non-HDL cholesterol, crude 3.3 2018 unchanged 2nd Mean total cholesterol, crude 4.5 2018 unchanged 2nd Page 1 of 6 Next →